je.st
news
Exclusive- India's Lupin, U.S. firms weigh bids for GSK's mature drugs: sources
2014-07-22 22:02:47| Biotech - Topix.net
Assuming a multiple of between two and three times those sales, the assets on the block could fetch between $3.5 billion and $5.0 billion , the sources said.
Tags: sources
exclusive
drugs
firms
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||